Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Biosimilars Market Portraiture
2.2 Global Biosimilars Market, by Product, 2016 (US$ Mn)
2.3 Global Biosimilars Market, by Application 2016 (US$ Mn)
2.4 Global Biosimilars Market, by Geography, 2016 (Value %)
Chapter 3 Global Biosimilars Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of cancer and chronic disease and geriatric population
3.2.2 Patent expiry of biologics and government initiatives to promote biosimilars
3.3 Market Restraints
3.3.1 High complexities involved in the manufacturing of biosimilars
3.3.2 Rigorous regulatory frame work governing their approval in countries around the world
3.4 Market Opportunities
3.4.1 Cost effectiveness of biosimilars in comparison to costly biological drugs.
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Biosimilars , by Key Players
Chapter 4 Global Biosimilar Market, By Type of Product
4.1 Introduction
4.2 Recombinant non – glycosylated proteins
4.3 Recombinant glycosylated proteins
4.4 Recombinant peptides
Chapter 5 Global Biosimilar Market, By Application
5.1 Market Analysis
5.2 Oncology
5.3 Chronic and autoimmune disease
5.4 Blood disorders
5.5 Growth hormone disease
5.6 Infectious disease
Chapter 6 Global Biosimilar Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa
Chapter 7 Company Profiles
7.1 Pfizer, Inc.
7.2 Sandoz International GmbH
7.3 Teva Pharmaceutical Industries Limited
7.4 Amgen Inc.
7.5 Biocon
7.6 Dr. Reddy’s Laboratories
7.7 F. Hoffman – La Roche Ltd.
7.8 Celltrion, Inc.
7.9 Samsung Bioepis
7.10 Eli Lily, Inc.
List of Figures
FIG. 1 Biosimilars Market: Research Methodology
FIG. 2 Global Biosimilars Market, by Product 2016 (US$ Mn)
FIG. 3 Global Biosimilars Market, by Application, 2016 (US$ Mn)
FIG. 4 Global Biosimilars Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography,2016
FIG. 6 Market Positioning of Key Biosimilars Vendors, 2016
FIG. 7 Recombinant non – glycosylated proteins Product Market, 2015 – 2025 (US$ Mn)
FIG. 8 Recombinant glycosylated proteins Product Market, 2015 – 2025 (US$ Mn)
FIG. 9 Recombinant peptides Product Market, 2015 – 2025 (US$ Mn)
FIG. 10 Oncology Application Market, 2015 – 2025 (US$ Mn)
FIG. 11 Chronic and autoimmune disease Appication Market, 2015 – 2025 (US$ Mn)
FIG. 12 Blood disorders Application Market, 2015 – 2025 (US$ Mn)
FIG. 13 Growth hormone disease Application Market, 2015 – 2025 (US$ Mn)
FIG. 14 Infectious disease Application Market, 2015 – 2025 (US$ Mn)
FIG. 15 North America Biosimilars Market , 2015 – 2025 (US$ Mn)
FIG. 16 Europe Biosimilars Market , 2015 – 2025 (US$ Mn)
FIG. 17 Asia-Pacific Biosimilars Market , 2015 – 2025 (US$ Mn)
FIG. 18 Latin America Biosimilars Market , 2015 – 2025 (US$ Mn)
FIG. 19 Middle East and Africa Biosimilars Market , 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Biosimilars Market, By Product, 2015-2025 (US$ Mn)
TABLE 2 Global Biosimilars Market, By Application, 2015-2025 (US$ Mn)
TABLE 3 Global Biosimilars Market, By Geography, 2015 – 2025 (US$ Mn)
TABLE 4 Pfizer, Inc. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 5 Sandoz International GmbH : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 6 Teva pharmaceutical Industries Ltd. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 7 Amgen Inc. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 8 Biocon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 9 Dr. Reddy’s Laboratories : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 10 F. Hoffman – La Roche Ltd. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 11 Celltrion, Inc. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 12 Samsung Bioepis : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
TABLE 13 Eli Lily, Inc. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)